MERZ PHARMA

In News

Teijin Pharma Limited and Merz Therapeutics GmbH Win Japanese Approval for XEOMIN® in Cervical Dystonia and Blepharospasm - BioPharma APAC

BioPharma APAC - Jun 22, 2026

Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan - Business Wire

Business Wire - Jun 19, 2026

Teijin & Merz Deepen Japan Hold with Key XEOMIN® Neurological Approval - BriefGlance

BriefGlance - Jun 19, 2026

Merz bets on China Parkinson’s market with Kvvit licensing deal - The Pharma Letter

The Pharma Letter - Jun 02, 2026

Merz v. Viatris on Appeal: Urgency Is Still Everything — But Not Every Signal Is Urgent - Wolters Kluwer

Wolters Kluwer - May 19, 2026

Merz Aesthetics Receives FDA Approval for RADIESSE® for the Treatment of Wrinkles in the Décolleté Area - Morningstar

Morningstar - Apr 08, 2026

Merz steps into the ring with Muhammad Ali-inspired Inbrija campaign - Fierce Pharma

Fierce Pharma - Feb 05, 2026

Merz Aesthetics celebrates Xeomin’s 15-year anniversary with refreshed brand campaign - Medical Marketing and Media

Medical Marketing and Media - Feb 11, 2026

Merz Aesthetics Extends Partnership With North Carolina Women’s Soccer Team - CSRwire

CSRwire - Feb 10, 2026

Merz's Xeomin ranks 1st in botulinum toxin imports in Korea for 7 consecutive years - koreabiomed.com

koreabiomed.com - Mar 09, 2026

Merz and A&O gain sales ban for generic fampridine products in Germany - JUVE Patent

JUVE Patent - Apr 20, 2026

Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity - BioSpace

BioSpace - Jan 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment